European Archives - Page 121 of 1632 - European Medical Journal

Women with PMOS Should Get Annual Review of Symptoms, Says NICE

Women with PMOS Should Get Annual Review of Symptoms, Says NICE

The National Institute for Health and Care Excellence has published new guidance on polyendocrine metabolic ovarian syndrome.

Cholesterol Pathway Disruption Drives DCM Cell Damage

New research identifies abnormal cholesterol signalling as a driver of cardiomyocyte dysfunction in dilated cardiomyopathy, revealing links between lipid metabolism, ER structure, and sarcomere organisation.

CRP May Predict Drug Response in Axial Spondyloarthritis

CRP May Predict Drug Response in Axial Spondyloarthritis

New real-world data shows that baseline CRP predicts TNF inhibitor retention in axial spondyloarthritis, but not for IL-17 inhibitors.

Skin Microbiome May Help Identify Cause of Death

A new multi-omics study suggests skin microbiome and metabolite profiles could help determine cause of death and estimate postmortem interval in forensic investigations.

Pills being placed in a person's hand

First patients enroll in Bundibugyo Ebola treatment trial

The PARTNERS trial has launched in the DRC as the country continues to battle an outbreak that has already led to more than 1,400 cases.

Reduced Infant Bathing Shows Lower Eczema Rates in Feasibility Trial

Reduced infant bathing frequency was associated with lower eczema rates at six months in a feasibility trial, suggesting a potential prevention approach.

Diabetes Drugs Lower Dementia Risk in Patients with Psychiatric Disorders

SGLT2s Lower Dementia Risk in Adults with Psychiatric Disorders

A 112,000-patient study links SGLT2 inhibitors to lower dementia risk in people with psychiatric disorders, pointing to a shared metabolic link.

The Netherlands Sees Rise in HCC Incidence Driven by MASLD

Liver cancer cases increased in the Netherlands between 2014 and 2022, driven by a rise in MASLD-related disease, while survival remained poor.

LEO Pharma bolsters rare skin disease focus by acquisition of Replay

LEO Pharma has acquired Replay’s herpes simplex virus gene therapy platform for $50m upfront.

Pulmonary Sarcoidosis MRI Shows Promise for Radiation-Free Monitoring

Low-field MRI provided radiation-free structural and functional assessment in pulmonary sarcoidosis, with functional measures correlating with lung function tests.